GlaxoSmithKline (Nimenrix And Mencevax) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

GlaxoSmithKline (Nimenrix And Mencevax) General Information

Description

Two quadrivalent meningitis ACWY vaccines of GlaxoSmithKline.. These vaccines are a single-dose meningococcal vaccines used to control outbreaks of meningococcal infection and for travelers to countries where the disease is endemic.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Other Healthcare
Acquirer
Primary Office
  • 980 Great West Road
  • Brentford TW8 9GS
  • England, United Kingdom
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

GlaxoSmithKline (Nimenrix And Mencevax) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore GlaxoSmithKline (Nimenrix And Mencevax)‘s full profile, request access.

Request a free trial

GlaxoSmithKline (Nimenrix And Mencevax) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore GlaxoSmithKline (Nimenrix And Mencevax)‘s full profile, request access.

Request a free trial